- China
- /
- Healthcare Services
- /
- SZSE:002219
New Journey Health Technology GroupLTD Third Quarter 2024 Earnings: CN¥0.002 loss per share (vs CN¥0.007 loss in 3Q 2023)
New Journey Health Technology GroupLTD (SZSE:002219) Third Quarter 2024 Results
Key Financial Results
- Revenue: CN¥860.5m (down 2.7% from 3Q 2023).
- Net loss: CN¥7.35m (loss narrowed by 69% from 3Q 2023).
- CN¥0.002 loss per share (improved from CN¥0.007 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
New Journey Health Technology GroupLTD shares are up 8.5% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 3 warning signs for New Journey Health Technology GroupLTD (1 is a bit concerning!) that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if New Journey Health Technology GroupLTD might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002219
New Journey Health Technology GroupLTD
Engages in the provision of medical services and pharmaceuticals products in China and internationally.
Low with imperfect balance sheet.